Harm reduction attempts to reduce the adverse consequences of drug use among persons who continue to use drugs. It developed in response to the excesses of a "zero tolerance approach". Harm reduction emphasizes practical rather than idealized goals. It has been expanded from illicit drugs to legal drugs and is grounded in the evolving public health and advocacy movements. Harm reduction has proved to be effective and it has gained increasing official acceptance; for example, it is now the basis of Canada's Drug Strategy. However, the concept is still poorly defined, as virtually any drug policy or programme, even abstinence-oriented programmes, attempt to reduce drug-related harm. The principle feature of harm reduction is the acceptance of the fact that some drug users cannot be expected to cease their drug use at the present time. Harm reduction is neutral about the long term goals of intervention while according a high priority to short-term realizable goals. Harm reduction should be neutral about legalization. The essence of the concept is to ameliorate adverse consequences of drug use while, at least in the short term, drug use continues.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/09595239500185371 | DOI Listing |
Health Justice
January 2025
Burnet Institute, Melbourne, Australia.
Background: During the COVID-19 pandemic, governments worldwide introduced law enforcement measures to deter and punish breaches of emergency public health orders. For example, in Victoria, Australia, discretionary fines of A$1,652 were issued for breaching stay-at-home orders, and A$4,957 fines for 'unlawful gatherings'; to date, approximately 30,000 fines remain outstanding or not paid in full. Studies globally have revealed how the expansion of policing powers produced significant collateral damage for marginalized populations, including people from low-income neighboorhoods, Indigenous Peoples, sex workers, and people from culturally diverse backgrounds.
View Article and Find Full Text PDFFront Psychol
January 2025
Department of Kinesiology, Pennsylvania State University, State College, PA, United States.
Introduction: Self-Determination Theory (SDT) examines human motivation in multiple domains; however, the only existing measure assessing SDT-informed behavioral regulations for drinking focuses on responsible drinker behaviors, rather than drinking , which is important given the alignment between SDT and harm reduction approaches to alcohol use. The aim of this study was to test the structural validity of the SDT-informed Comprehensive Relative Autonomy Index for Drinking (CRAI-Drinking) among college students.
Methods: Participants included two convenience samples with a total of 630 adult drinkers (M = 21.
Introduction: Fentanyl and xylazine test strips (FTS, XTS) are simple point-of-care tests that determine the presence of fentanyl or xylazine in a substance before use. Access to FTS and XTS is limited. For pharmacists who are willing to sell an FTS, there is little guidance about how to implement FTS sales and counseling as no training for community pharmacists regarding FTS and XTS exists.
View Article and Find Full Text PDFDiscov Public Health
January 2025
British Columbia Centre on Substance Use, 1045 Howe Street, Vancouver, BC V6Z 1Y6 Canada.
Following the onset of the COVID-19 pandemic, an ever-increasing number of people have died from the toxic drug supply in Canada. Emerging evidence suggests that reduced access to harm reduction services has been a contributing factor. However, the precise impacts of the pandemic on supervised consumption service (SCS) delivery have not been well characterized.
View Article and Find Full Text PDFAm J Nurs
February 2025
Brittany L. Carney and Vanessa Loukas are NPs and Colleen T. LaBelle is in nursing leadership in the general internal medicine section, Department of Medicine, Boston Medical Center (BMC); all 3 are assistant professors of medicine in the Boston University Chobanian and Avedisian School of Medicine. Carney and Loukas are also clinical nurse educators at BMC's Grayken Center for Addiction Training and Technical Assistance, where LaBelle is the executive director, and Carney is an NP in BMC's Adolescent Clinic. Contact author: Brittany L. Carney, The authors have disclosed no potential conflicts of interest, financial or otherwise.
Barriers remain to applying this approach with people who use drugs.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!